Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 7, 2008 - Issue 5
Submit an article Journal homepage
186
Views
13
CrossRef citations to date
0
Altmetric
Review

Risk of skin cancer in the drug treatment of rheumatoid arthritis

Eliza F Chakravarty Assistant Professor of Medicine Stanford University School of Medicine, Division of Immunology and Rheumatology, 1000 Welch Road, Suite 203, Palo Alto, Stanford, CA 94304, USA +1 650 725 5070; +1 650 723 9656; [email protected]
, MD MS &
Evan R Farmer Virginia Commonwealth University School of Medicine, Departments of Pathology and Dermatology, Richmond, VA, USA
, MD
Pages 539-546 | Published online: 01 Sep 2008

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Claudine Piérard-Franchimont, Gérald E Piérard & Pascale Quatresooz. (2011) Focus on skin cancer association and progression under TNF antagonist therapy. Expert Opinion on Biological Therapy 11:9, pages 1215-1222.
Read now

Articles from other publishers (12)

Wenhui Xie, Shiyu Xiao, Yanrong Huang, Xiaoying Sun, Dai Gao, LanLan Ji, Guangtao Li & Zhuoli Zhang. (2020) A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy. Rheumatology 59:5, pages 930-939.
Crossref
Samera Vaseer & Eliza F. Chakravarty. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology 2048 2065.e6 .
Catherine M. Olsen, Kimme L. Hyrich, Lani L. Knight & Adèle C. Green. (2016) Melanoma risk in patients with rheumatoid arthritis treated with tumour necrosis factor alpha inhibitors: a systematic review and meta-analysis. Melanoma Research 26:5, pages 517-523.
Crossref
Teresa A. Simon, Adam Thompson, Kunal K. Gandhi, Marc C. Hochberg & Samy Suissa. (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Research & Therapy 17:1.
Crossref
Dana M. Hornbeak & Jennifer E. Thorne. (2015) Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention. Taiwan Journal of Ophthalmology 5:4, pages 156-163.
Crossref
Jungmin Lee & Kofi Clarke. (2015) Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma—challenges in management. International Journal of Colorectal Disease 30:12, pages 1595-1602.
Crossref
Jean H Tayar, Maria A Lopez-Olivo & Maria E Suarez-Almazor. (2013) Adalimumab: 8 years of experience in rheumatoid arthritis. International Journal of Clinical Rheumatology 8:2, pages 165-184.
Crossref
Eliza F. Chakravarty. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology 1934 1950.e6 .
Marta Ferran Farrés. (2012) Efectos secundarios cutáneos de los fármacos antagonistas del factor de necrosis tumoral α. Piel 27:10, pages 558-569.
Crossref
Loreto Carmona, Lydia Abasolo, Miguel A. Descalzo, Beatriz Pérez-Zafrilla, Agustí Sellas, Francisco de Abajo & Juan J. Gomez-Reino. (2011) Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists. Seminars in Arthritis and Rheumatism 41:1, pages 71-80.
Crossref
Paul Chapman, Lee Cranmer, W.G. Dixon, K.L. Hyrich, John R. Patterson, D.P.M. Symmons, Mary Toporcer & Michael J. Mastrangelo. (2010) The Role of Anti–Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?. Seminars in Oncology 37:1, pages 11-19.
Crossref
C. Maire, F. Delesalle, O. Carpentier, P. Lequint, E. Delaporte & P. Thomas. (2009) Carcinomes basocellulaires multiples après traitement d’un psoriasis par étanercept. Annales de Dermatologie et de Vénéréologie 136:4, pages 355-359.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.